Lutetium Lu 177 dotatate
Lutetium Lu 177 dotatate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Lutathera. Available dosage form: injection.
Drug Details
- Generic Name
- Lutetium Lu 177 dotatate
- Brand Names
- Lutathera
- Application Number
- NDA208700
- Sponsor
- Advanced Accelerator Applications USA, Inc
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- LUTETIUM OXODOTREOTIDE LU-177
Indications and Usage
1 INDICATIONS AND USAGE LUTATHERA is indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors. LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors.